CABA — Cabaletta Bio, Inc. stock price, charts and financials

QT66Cabaletta Bio, Inc.

Cabaletta Bio, Inc. (NASDAQ: CABA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
2.77
+0.08+2.97%
OverviewShort InterestFilings
CABAQT66Cabaletta Bio, Inc.·NASDAQ
2.77+2.97%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 23, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 11, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 03, 20268-KCurrent report
Jun 01, 2026DEFA14AAdditional proxy soliciting materials
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 202610-QQuarterly report
May 14, 20268-KCurrent report
May 14, 20268-KCurrent report
May 04, 20268-KCurrent report
May 04, 2026424B5Prospectus
May 04, 20268-KCurrent report
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 20, 20268-KCurrent report
Apr 17, 2026PRE 14APreliminary proxy statement
#1 / 25 of 311
Page
▼
/ 13